RadNet, Inc.
NASDAQ:RDNTMedical - Diagnostics & Research
+$1.53 today
- Market cap
- $5.66B
- Beta
- 1.39
- P/E (TTM)
- -295.1
- EPS (TTM)
- -$0.18
Volume 0.81M
Average 0.80M
RDNT Operating Cash Flow
Cash generated by the company's core business operations during the period.
RadNet, Inc.NASDAQ: RDNT
Operating Cash Flow · Q3 FY2026 · quarter ended Sep 2026
Operating cash flow growth accelerates
Q3 FY2026 operating cash flow of $90.57M rose 71.4% year over year, ahead of the +32.8% change in trailing-twelve-month operating cash flow. Sequentially, it rose 3.2% from the prior quarter. Over 3 fiscal years it compounded at +26.8% a year.
Context
- Operating cash flow amounted to 14.6% of revenue in FY2025, up 1.9 pp from a year earlier.
- Operating cash flow increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +71.4% holds above the trailing-twelve-month pace of +32.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 298.82M USD
- Year-over-year change
- +28.2%
- 4-year CAGR
- +18.9%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 298.82M | +28.2% |
| FY2024 | 2024-12-31 | 233.02M | +5.5% |
| FY2023 | 2023-12-31 | 220.86M | +50.8% |
| FY2022 | 2022-12-31 | 146.42M | -2.1% |
| FY2021 | 2021-12-31 | 149.49M | — |
Operating Cash Flow vs competitors
How RDNT compares with its peers on the latest reported figures
- RDNT's LTM Sep 2026 operating cash flow of $341.47M is the 2nd largest of the 7 companies compared; the peer median is $23.01M.
- Its year-over-year change of +32.8% is the highest of 7, against a peer median of -8.9%.
- Operating cash flow amounts to 14.3% of revenue for RDNT, versus a peer median of 10.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.42B | -29.0% | -2.0% | 7.0% | |
| LTM Sep 2026 | $341.47M | +32.8% | +26.8% | 14.3% | |
| LTM Jun 2026 | $190.4M | +14.8% | -21.2% | 5.4% | |
| LTM Dec 2025 | $43.17M | +18.0% | -2.0% | 331.6% | |
| LTM Mar 2026 | $28.94M | +11.2% | +35.4% | 33.5% | |
LMRILumexa Imaging Holdings, Inc. Common Stock | FY2025 | $17.07M | -58.1% | — | 1.7% |
| LTM Mar 2026 | $14.92M | -54.4% | -57.8% | 14.5% | |
| Peer median (excluding RDNT) | $23.01M | -8.9% | -2.0% | 10.7% | |
Competitors are the stored peer set for RDNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 44.32M | 33.61M | 30.34M | 38.84M | 46.77M |
| Depreciation & Amortization | 170.66M | 184.72M | 189.49M | 137.84M | 152.13M |
| Deferred Income Tax | (21.49M) | 13.36M | 0 | 0 | 10.83M |
| Stock-Based Compensation | 25.2M | 23.77M | 26.79M | 29.83M | 54.6M |
| Change in Working Capital | (92.13M) | (58.7M) | (40.27M) | (56.49M) | (9.75M) |
| Accounts Receivables | (5.89M) | (30.08M) | 2.65M | (21.77M) | (9.56M) |
| Inventory | (87.67M) | 0 | 0 | 0 | 0 |
| Accounts Payables | 9.92M | 49.78M | 15.09M | 37.12M | 52.42M |
| Other Working Capital | (8.49M) | (78.4M) | (58.01M) | (71.84M) | (52.61M) |
| Other Non-Cash Items | 22.93M | (50.35M) | 14.52M | 83M | 44.24M |
| Operating Cash Flow | 149.49M | 146.42M | 220.86M | 233.02M | 298.82M |
| Capital Expenditures | (220.7M) | (249.41M) | (176.6M) | (188.07M) | (213.25M) |
| Acquisitions (Net) | (1.44M) | (1.44M) | (24.95M) | (45.16M) | (133.42M) |
| Purchases of Investments | (1.44M) | (1.44M) | 0 | 0 | 0 |
| Sales of Investments | 1.44M | 1.44M | 0 | 0 | 0 |
| Other Investing Activities | 625K | 3.9M | 83K | 157K | 2.81M |
| Investing Cash Flow | (221.51M) | (246.95M) | (201.47M) | (233.07M) | (343.87M) |
| Debt Repayment | 94.48M | 94.25M | (43.99M) | 165.33M | 71.22M |
| Common Stock Issued | 488K | 294K | 245.83M | 218.39M | 5.45M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 9.71M | (893K) | (6.2M) | 14.23M | (4.46M) |
| Financing Cash Flow | 104.67M | 93.65M | 195.64M | 397.95M | 72.21M |
| Effect of Forex Changes | (65K) | 113K | (292K) | (453K) | 33K |
| Net Change in Cash | 32.59M | (6.77M) | 214.74M | 397.45M | 27.2M |
| Free Cash Flow | (71.2M) | (103M) | 44.26M | 44.95M | 85.57M |
RadNet, Inc.
NASDAQ:RDNT
Intrinsic Alpha fair value
Locked
Current Price
$71.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.